Company Filing History:
Years Active: 2025
Title: The Innovations of Peter J Rohweder
Introduction
Peter J Rohweder is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.
Latest Patents
Peter J Rohweder holds a patent for a groundbreaking invention titled "Chemically Controlled Monoclonal Antibody Target Engagement." This patent represents a significant advancement in the ability to control and enhance the effectiveness of monoclonal antibodies in therapeutic settings. He has 1 patent to his name, reflecting his innovative contributions to the field.
Career Highlights
Rohweder is affiliated with the University of California, where he continues to engage in research and development. His work at the university allows him to collaborate with other leading scientists and contribute to cutting-edge research in biotechnology.
Collaborations
Throughout his career, Peter J Rohweder has worked alongside esteemed colleagues such as Charles S Craik and Kevan M Shokat. These collaborations have further enriched his research and have led to advancements in the understanding of monoclonal antibodies.
Conclusion
Peter J Rohweder's contributions to the field of biotechnology, particularly through his patent on monoclonal antibodies, highlight the vital role of innovation in advancing medical science. His work continues to inspire future developments in the industry.